Abstract
We studied the efficacy of nimodipine in severely head-injured patients in a randomized study. Of 176 patients who received nimodipine, 2 mg/h iv for 2 day, 53% had a favorable outcome (moderate or good recovery). Of 175 control patients, 49% had a favorable outcome. This difference was not statistically significant buf does not exclude the possibility that a study of a larger number of patients could show a clinically useful benefit.
Original language | English |
---|---|
Pages (from-to) | S545-S550 |
Number of pages | 6 |
Journal | Journal of Neurotrauma |
Volume | 9 |
Publication status | Published - May 1992 |
Event | 9TH ANNUAL MEETING OF THE NEUROTRAUMA SOC - NEW ORLEANS, Lao People's Democratic Republic Duration: 9 Nov 1991 → 10 Nov 1991 |
Keywords
- SUBARACHNOID HEMORRHAGE
- PRETREATMENT